Table 2 Indications and surgical outcome
Variable | Overall | NG (n = 17) | IFG/IGT (n = 22) | DM (n = 30) | p-Value* |
|---|---|---|---|---|---|
Histopathological type | |||||
PDAC [n] (%) NET [n] (%) IPMN [n] (%) Metastasis [n] (%) CP [n] (%) Other [n] (%) | 21 (30.4) 7 (10.1) 23 (33.3) 5 (7.2) 5 (7.2) 8 (11.6) | 4 (23.5) 1 (5.9) 8 (47.1) 1 (5.9) 1 (5.9) 2 (11.8) | 3 (13.6) 3 (13.6) 8 (36.4) 2 (9.1) 2 (9.1) 4 (18.2) | 14 (46.7) 3 (10) 7 (23.3) 2 (6.7) 2 (6.7) 2 (6.7) | 0.52 |
Complications CDC ≥ 3 [n] (%) | 23 (33) | 4 (23.5) | 9 (40.9) | 10 (33.3) | 0.52 |
POPF B/C [n] (%) | 22 (31.8) | 5 (22.7) | 8 (36.4) | 9 (40.9) | 0.73 |
PPH [n] (%) | 5 (7.25) | 2 (40) | 1 (20) | 2 (40) | 0.67 |
Length of hospital stay [days] (%) | 12 (9–17) | 9 (8-10.5) | 12 (9.8–16.3) | 13.5 (11-22.3) | < 0.01 |
Type of operation [n] (%) | |||||
Open Laparoscopic Robot-assisted | 42 (60.9) 12 (17.4) 15 (21.7) | 5 (29.4) 3 (17.6) 9 (52.9) | 13 (63.6) 4 (18.2) 4 (18.2) | 23 (76.7) 5 (16.7) 2 (6.7) | < 0.01 |
Splenectomy [n] (%) | 53 (76.8) | 13 (76.5) | 15 (68.2) | 25 (83.3) | 0.44 |
MVR [n] (%) | 12 (17.4) | 2 (11.8) | 4 (18.2) | 6 (20) | 0.77 |
Median duration of operation [min] (IQR) | 231 (166–279) | 215 (173–245) | 232 (178.3–279) | 234 (148.8–294.5) | 0.63 |
30-day mortality | 0 | 0 | 0 | 0 | n.a. |
In-hospital mortality | 0 | 0 | 0 | 0 | n.a. |